Oramed Pharmaceuticals (ORMP) Deferred Taxes (2025 - 2026)

Oramed Pharmaceuticals (ORMP) reported Deferred Taxes of -$9.8 million for Q1 2026, down 98460.0% quarter-over-quarter from $10000.0 in Q4 2025.

Oramed Pharmaceuticals (ORMP) Deferred Taxes (2025 - 2026) Analysis & Trends

Oramed Pharmaceuticals has reported Deferred Taxes for 2 years, with the latest figure at -$9.8 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-	-859,000.00
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn	-65.30 Mn
9	Abivax	91.71 Bn	91.71 Bn	-	-
10	Oramed Pharmaceuticals	151.47 Mn	133.31 Mn	-	-9.84 Mn

Download Data